Chemours (CC) Net Income towards Common Stockholders (2014 - 2026)

Chemours' Net Income towards Common Stockholders history runs 13 years deep, the most recent figure standing at -$29.0 million for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders fell 480.0% year-over-year to -$29.0 million; the TTM figure through Mar 2026 stood at -$377.0 million (down 3241.67% YoY), while the FY2025 annual figure was $100.0 million, down 13.79% from the prior year.
• Net Income towards Common Stockholders was -$29.0 million for Q1 2026 at Chemours, down from -$15.0 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $240.0 million in Q3 2022 to a low of -$379.0 million in Q2 2025.
• Historically, Net Income towards Common Stockholders has averaged $3.3 million across 5 years, with a median of -$5.0 million in 2025.
• Biggest YoY gain for Net Income towards Common Stockholders was 243.75% in 2025; the steepest drop was 731.67% in 2025.
• A 5-year view of Net Income towards Common Stockholders shows it stood at -$77.0 million in 2022, then soared by 84.42% to -$12.0 million in 2023, then grew by 8.33% to -$11.0 million in 2024, then slumped by 36.36% to -$15.0 million in 2025, then sank by 93.33% to -$29.0 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$29.0 million (Q1 2026), -$15.0 million (Q4 2025), and $46.0 million (Q3 2025), per Business Quant data.